Uploaded March 2026 | Updated September 2026, 2 weeks ago

---

Drug discovery used to be controlled by pharma and biotech. Now, AI-powered tools are opening the door to new players.

In this clip, Jack Hidary, CEO of SandboxAQ, explains how AI and advanced simulation tools are democratizing medicine: by enabling sovereign nations, academic institutions, and nontraditional players to develop lifesaving drugs.

Countries in the GCC, including Bahrain, are now running early-stage clinical trials with state-of-the-art hospitals and modern infrastructure — something we rarely saw just a few years ago.

AI isn’t just accelerating drug discovery. It’s expanding who gets to participate.

Watch the full interview here: youtu.be/T35wzsZVsM0

#sandboxaq #lqms #aqbiosim